These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36988544)

  • 21. Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis.
    Wang K; Nguyen M; Chen Y; Hoofnagle AN; Becker JO; Zelnick LR; Kundzins J; Goodling A; Himmelfarb J; Kestenbaum B
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):530-538. PubMed ID: 32152064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.
    Wang K; Kestenbaum B
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1291-1296. PubMed ID: 29490976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does HIV infection promote early kidney injury in women?
    Jotwani V; Scherzer R; Abraham A; Estrella MM; Bennett M; Devarajan P; Anastos K; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Grunfeld C; Parikh CR; Shlipak MG
    Antivir Ther; 2014; 19(1):79-87. PubMed ID: 23970313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.
    Margolick JB; Jacobson LP; Schwartz GJ; Abraham AG; Darilay AT; Kingsley LA; Witt MD; Palella FJ
    PLoS One; 2014; 9(2):e86311. PubMed ID: 24516530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV.
    Edrosolan KA; Shlipak MG; Scherzer R; Estrella MM; Gustafson D; Karim R; Fisher M; Cohen M; Kassaye S; Dumond J; Abraham A; McCulloch CE; Ascher SB
    AIDS; 2024 May; 38(6):813-824. PubMed ID: 38224361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tubular Secretion in CKD.
    Suchy-Dicey AM; Laha T; Hoofnagle A; Newitt R; Sirich TL; Meyer TW; Thummel KE; Yanez ND; Himmelfarb J; Weiss NS; Kestenbaum BR
    J Am Soc Nephrol; 2016 Jul; 27(7):2148-55. PubMed ID: 26614381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
    Baxi SM; Scherzer R; Greenblatt RM; Minkoff H; Sharma A; Cohen M; Young MA; Abraham AG; Shlipak MG;
    AIDS; 2016 Feb; 30(4):609-18. PubMed ID: 26558723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.
    Jotwani V; Li Y; Grunfeld C; Choi AI; Shlipak MG
    Am J Kidney Dis; 2012 May; 59(5):628-35. PubMed ID: 22206742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV.
    Baxi SM; Scherzer R; Jotwani V; Estrella MM; Abraham AG; Parikh CR; Bennett MR; Cohen MH; Nowicki MJ; Gustafson DR; Sharma A; Young MA; Shlipak MG;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):e138-e145. PubMed ID: 27759575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women.
    Estrella MM; Abraham AG; Jing Y; Parekh RS; Tien PC; Merenstein D; Pearce CL; Anastos K; Cohen MH; Dehovitz JA; Gange SJ
    AIDS Res Hum Retroviruses; 2013 May; 29(5):755-60. PubMed ID: 23273313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.
    Ascher SB; Scherzer R; Estrella MM; Zhang WR; Muiru AN; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Young M; Sharma A; Cohen MH; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1321-1329. PubMed ID: 30154221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.
    Scherzer R; Lin H; Abraham A; Thiessen-Philbrook H; Parikh CR; Bennett M; Cohen MH; Nowicki M; Gustafson DR; Sharma A; Young M; Tien P; Jotwani V; Shlipak MG
    Nephrol Dial Transplant; 2016 Sep; 31(9):1478-85. PubMed ID: 26754833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.
    Longo AL; Lepira FB; Sumaili EK; Makulo JR; Mukumbi H; Bukabau JB; Mokoli VM; Kayembe PK; Nseka NM
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):59-64. PubMed ID: 21926635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
    Estrella MM; Parekh RS; Abraham A; Astor BC; Szczech LA; Anastos K; Dehovitz JA; Merenstein DJ; Pearce CL; Tien PC; Cohen MH; Gange SJ
    J Acquir Immune Defic Syndr; 2010 Oct; 55(2):217-20. PubMed ID: 20581688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of kidney proximal tubular secretion in critical illness.
    Bhatraju PK; Chai XY; Sathe NA; Ruzinski J; Siew ED; Himmelfarb J; Hoofnagle AN; Wurfel MM; Kestenbaum BR
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33886506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort.
    Brito RM; Nguyen DT; Johnson JR; Lai EJ; Castro RE; Albert AM; Barnes AS; Graviss EA; Suki WN
    PLoS One; 2019; 14(4):e0215575. PubMed ID: 30995263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.